Catalyst Wire Dossier Catalyst Wire Dossier

CCR5-edited autologous T-cells (ZFN)

· Sangamo Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCR5-edited autologous T-cells (ZFN), covering 2015-03-13 to 2015-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients [Phase 1]

See pricing